<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30165893</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>19</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1756-9966</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>37</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of experimental &amp; clinical cancer research : CR</Title>                <ISOAbbreviation>J. Exp. Clin. Cancer Res.</ISOAbbreviation>            </Journal>            <ArticleTitle>BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>209</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13046-018-0885-1</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Angiogenesis has become an attractive target for cancer therapy. However, despite the initial success of anti-VEGF (Vascular endothelial growth factor) therapies, the overall survival appears only modestly improved and resistance to therapy often develops. Other anti-angiogenic targets are thus urgently needed. The predominant expression of the type I BMP (bone morphogenetic protein) receptor ALK1 (activin receptor-like kinase 1) in endothelial cells makes it an attractive target, and phase I/II trials are currently being conducted. ALK1 binds with strong affinity to two ligands that belong to the TGF-ß family, BMP9 and BMP10. In the present work, we addressed their specific roles in tumor angiogenesis, cancer development and metastasis in a mammary cancer model.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">For this, we used knockout (KO) mice for BMP9 (constitutive Gdf2-deficient), for BMP10 (inducible Bmp10-deficient) and double KO mice (Gdf2 and Bmp10) in a syngeneic immunocompetent orthotopic mouse model of spontaneous metastatic breast cancer (E0771).</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Our studies demonstrate a specific role for BMP9 in the E0771 mammary carcinoma model. Gdf2 deletion increased tumor growth while inhibiting vessel maturation and tumor perfusion. Gdf2 deletion also increased the number and the mean size of lung metastases. On the other hand, Bmp10 deletion did not significantly affect the E0771 mammary model and the double deletion (Gdf2 and Bmp10) did not lead to a stronger phenotype than the single Gdf2 deletion.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Altogether, our data show that in a tumor environment BMP9 and BMP10 play different roles and thus blocking their shared receptor ALK1 is maybe not appropriate. Indeed, BMP9, but not BMP10, acts as a quiescence factor on tumor growth, lung metastasis and vessel normalization. Our results also support that activating rather than blocking the BMP9 pathway could be a new strategy for tumor vessel normalization in order to treat breast cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Ouarné</LastName>                    <ForeName>Marie</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, 38000, Grenoble, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bouvard</LastName>                    <ForeName>Claire</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, 38000, Grenoble, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Boneva</LastName>                    <ForeName>Gabriela</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, 38000, Grenoble, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mallet</LastName>                    <ForeName>Christine</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, 38000, Grenoble, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ribeiro</LastName>                    <ForeName>Johnny</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Inserm, U1033, Lyon, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Université Claude Bernard Lyon 1, Villeurbanne, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>, Faculté de Médecine de Lyon Est, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Desroches-Castan</LastName>                    <ForeName>Agnès</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, 38000, Grenoble, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Soleilhac</LastName>                    <ForeName>Emmanuelle</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie à Grande Echelle, 38000, Grenoble, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tillet</LastName>                    <ForeName>Emmanuelle</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, 38000, Grenoble, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Peyruchaud</LastName>                    <ForeName>Olivier</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>Inserm, U1033, Lyon, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Université Claude Bernard Lyon 1, Villeurbanne, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>, Faculté de Médecine de Lyon Est, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bailly</LastName>                    <ForeName>Sabine</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, 38000, Grenoble, France. sabine.bailly@cea.fr.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>J Exp Clin Cancer Res</MedlineTA>            <NlmUniqueID>8308647</NlmUniqueID>            <ISSNLinking>0392-9078</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C119152">Bmp10 protein, mouse</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D019485">Bone Morphogenetic Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C526108">Gdf2 protein, mouse</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D055427">Growth Differentiation Factor 2</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.11.30</RegistryNumber>                <NameOfSubstance UI="D030201">Activin Receptors, Type I</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.11.30</RegistryNumber>                <NameOfSubstance UI="C498931">Acvrl1 protein, mouse</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2007 Mar 1;109(5):1953-61</RefSource>                <PMID Version="1">17068149</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2005 Jul 1;280(26):25111-8</RefSource>                <PMID Version="1">15851468</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Dec 20;7(51):84314-84325</RefSource>                <PMID Version="1">27741515</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2012 Aug 10;287(33):27313-25</RefSource>                <PMID Version="1">22718755</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2016 Jul 29;7:12329</RefSource>                <PMID Version="1">27470974</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Med. 2010 Jan 18;207(1):85-100</RefSource>                <PMID Version="1">20065063</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013 Jul 23;8(7):e69535</RefSource>                <PMID Version="1">23936038</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Oncol. 2016 Dec;10(10):1603-1620</RefSource>                <PMID Version="1">28949445</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 May 07;9(5):e96816</RefSource>                <PMID Version="1">24805814</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):E3207-15</RefSource>                <PMID Version="1">26056270</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Mol Life Sci. 2012 Jan;69(2):313-24</RefSource>                <PMID Version="1">21710321</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Angiogenesis. 2017 Nov;20(4):409-426</RefSource>                <PMID Version="1">28660302</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Biol Rep. 2014 Mar;41(3):1373-83</RefSource>                <PMID Version="1">24413988</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genesis. 2006 May;44(5):233-8</RefSource>                <PMID Version="1">16652364</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2011 Mar 4;144(5):646-74</RefSource>                <PMID Version="1">21376230</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2005 Nov-Dec;25(6B):3905-15</RefSource>                <PMID Version="1">16312045</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 1994 Dec;8(4):345-51</RefSource>                <PMID Version="1">7894484</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11887-92</RefSource>                <PMID Version="1">23812757</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2626-31</RefSource>                <PMID Version="1">10716993</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood Cancer J. 2014 Mar 21;4:e196</RefSource>                <PMID Version="1">24658374</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2011 Feb 15;71(4):1362-73</RefSource>                <PMID Version="1">21212415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2015 Jun 15;75(12):2445-56</RefSource>                <PMID Version="1">26077471</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Thorac Oncol. 2016 Nov;11(11):2018-2021</RefSource>                <PMID Version="1">27449804</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Development. 2004 May;131(9):2219-31</RefSource>                <PMID Version="1">15073151</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Res Rev. 2017 Nov;37(6):1231-1274</RefSource>                <PMID Version="1">28643862</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2010 Oct;101(10):2137-44</RefSource>                <PMID Version="1">20608934</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cold Spring Harb Perspect Biol. 2018 Feb 1;10(2):null</RefSource>                <PMID Version="1">28348038</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Soc Trans. 2016 Aug 15;44(4):1142-9</RefSource>                <PMID Version="1">27528762</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2013 Jul 25;122(4):598-607</RefSource>                <PMID Version="1">23741013</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Biophys Res Commun. 2005 Jul 29;333(2):328-35</RefSource>                <PMID Version="1">15961063</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2010 Feb;9(2):379-88</RefSource>                <PMID Version="1">20124460</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 1996 Jun;13(2):189-95</RefSource>                <PMID Version="1">8640225</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Circ Res. 2008 Apr 25;102(8):914-22</RefSource>                <PMID Version="1">18309101</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2000 Jun 16;275(24):17937-45</RefSource>                <PMID Version="1">10849432</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mech Dev. 1999 Feb;80(2):181-4</RefSource>                <PMID Version="1">10072785</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2015 Aug 14;349(6249):694-5</RefSource>                <PMID Version="1">26273044</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2014 Nov 10;26(5):605-22</RefSource>                <PMID Version="1">25517747</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Oncol (Dordr). 2014 Oct;37(5):363-75</RefSource>                <PMID Version="1">25209393</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2012 Jun 21;119(25):6162-71</RefSource>                <PMID Version="1">22566602</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 May 9;8(19):30621-30643</RefSource>                <PMID Version="1">28430642</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neoplasia. 2015 Nov;17(11):826-38</RefSource>                <PMID Version="1">26678910</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2012 Jan 17;21(1):66-81</RefSource>                <PMID Version="1">22264789</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Res Clin Oncol. 2011 Nov;137(11):1687-96</RefSource>                <PMID Version="1">21892652</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2016 Dec 12;30(6):953-967</RefSource>                <PMID Version="1">27960088</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2011 Jun 30;117(26):6999-7006</RefSource>                <PMID Version="1">21467543</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 2000 Nov;26(3):328-31</RefSource>                <PMID Version="1">11062473</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Microcirculation. 2010 Apr;17(3):206-25</RefSource>                <PMID Version="1">20374484</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2012 May 25;287(22):18551-61</RefSource>                <PMID Version="1">22493445</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2014 Jun 1;20(11):2838-45</RefSource>                <PMID Version="1">24714770</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2016 Dec 1;122(23):3641-3649</RefSource>                <PMID Version="1">27648727</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D030201" MajorTopicYN="N">Activin Receptors, Type I</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019485" MajorTopicYN="N">Bone Morphogenetic Proteins</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004730" MajorTopicYN="N">Endothelium, Vascular</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055427" MajorTopicYN="N">Growth Differentiation Factor 2</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015674" MajorTopicYN="N">Mammary Neoplasms, Animal</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">BMP10</Keyword>            <Keyword MajorTopicYN="N">BMP9</Keyword>            <Keyword MajorTopicYN="N">E0771</Keyword>            <Keyword MajorTopicYN="N">Mammary tumor</Keyword>            <Keyword MajorTopicYN="N">Metastasis</Keyword>            <Keyword MajorTopicYN="N">Tumor angiogenesis</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30165893</ArticleId>            <ArticleId IdType="doi">10.1186/s13046-018-0885-1</ArticleId>            <ArticleId IdType="pii">10.1186/s13046-018-0885-1</ArticleId>            <ArticleId IdType="pmc">PMC6118004</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>